MyAverix Finance
SHG · Healthcare
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd (600332)
Medical Distribution
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd (600332) is listed on SHG in the Healthcare sector. Industry: Medical Distribution. As of 2026-03-28, reported market cap is $37.33B, P/E ratio is 12.55, net margin is 3.8%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for 600332
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd (600332) — FAQ
What is Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd's market cap?
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd (600332) has a reported market cap of $37.33B (data as of 2026-03-28).
What is 600332's P/E ratio?
The price-to-earnings (P/E) ratio for Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd (600332) is 12.55 (data as of 2026-03-28).
Does Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd pay a dividend?
Dividend yield is not available in the current snapshot for Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd (600332). Check the MyAverix Finance app for the latest dividend data.
What sector is Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd in?
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd (600332) is classified in the Healthcare sector (Medical Distribution industry).
What exchange is 600332 listed on?
600332 is listed on SHG.
What is Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd's net margin?
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd (600332) reports a net margin of 3.8% (data as of 2026-03-28).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.